Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0533
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis ; day:17 ; month:9 ; year:2018 ; pages:1-18
Acta neuropathologica ; (17.9.2018), 1-18
- Urheber
-
Hughes, Craig D.
- Beteiligte Personen und Organisationen
-
Choi, Minee L.
Ryten, Mina
Hopkins, Lee
Drews, Anna
Botía, Juan A.
Iljina, Maria
Rodrigues, Magarida
Gagliano, Sarah A.
Gandhi, Sonia
Bryant, Clare
Klenerman, David
SpringerLink (Online service)
- DOI
-
10.1007/s00401-018-1907-y
- URN
-
urn:nbn:de:101:1-2018110314271157143873
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hughes, Craig D.
- Choi, Minee L.
- Ryten, Mina
- Hopkins, Lee
- Drews, Anna
- Botía, Juan A.
- Iljina, Maria
- Rodrigues, Magarida
- Gagliano, Sarah A.
- Gandhi, Sonia
- Bryant, Clare
- Klenerman, David
- SpringerLink (Online service)
Ähnliche Objekte (12)
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
Transmission of alpha-synuclein in Parkinson’s disease
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
The role of alpha-synuclein on transcriptional deregulation in Parkinson’s disease
Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells
Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson’s Disease
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
Transmission of alpha-synuclein in Parkinson’s disease
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
The role of alpha-synuclein on transcriptional deregulation in Parkinson’s disease
Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells
Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson’s Disease
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
Transmission of alpha-synuclein in Parkinson’s disease
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
The role of alpha-synuclein on transcriptional deregulation in Parkinson’s disease
Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells